KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Free Cash Flow (2016 - 2025)

Evolent Health (EVH) has 11 years of Free Cash Flow data on record, last reported at $41.0 million in Q4 2025.

  • For Q4 2025, Free Cash Flow rose 226.73% year-over-year to $41.0 million; the TTM value through Dec 2025 reached $4.8 million, up 177.59%, while the annual FY2025 figure was $4.8 million, 177.59% up from the prior year.
  • Free Cash Flow reached $41.0 million in Q4 2025 per EVH's latest filing, up from $6.8 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $83.3 million in Q4 2023 and bottomed at -$66.0 million in Q1 2022.
  • Average Free Cash Flow over 5 years is $4.8 million, with a median of $2.0 million recorded in 2022.
  • Peak YoY movement for Free Cash Flow: skyrocketed 502.64% in 2023, then plummeted 820.09% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at $66.7 million in 2021, then tumbled by 62.57% to $25.0 million in 2022, then skyrocketed by 233.96% to $83.3 million in 2023, then plummeted by 138.86% to -$32.4 million in 2024, then skyrocketed by 226.73% to $41.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Free Cash Flow were $41.0 million in Q4 2025, $6.8 million in Q3 2025, and -$39.1 million in Q2 2025.